Predict your next investment

Advaite company logo
HEALTHCARE | Biotechnology
advaite.com

See what CB Insights has to offer

Founded Year

2017

About Advaite

Adviate is a biotech company focused on developing novel therapeutics and diagnostics to help patients suffering from a variety of debilitating diseases, primarily within the oncology space.

Advaite Headquarter Location

5 Great Valley Parkway Suite 125

Malvern, Pennsylvania, 19355,

United States

484-842-0220

Latest Advaite News

Coronavirus company news summary – Novacyt launches two new lateral flow tests – BGI and Advaite partner on Covid-19 diagnostic solutions

Jun 30, 2021

30 Jun 2021 (Last Updated June 30th, 2021 10:17) Share Article Novacyt is scheduled to launch two PathFlow Covid-19 antigen lateral flow tests (LFTs), strengthening the company’s Covid-19 testing portfolio and expanding its footing in point-of-care solutions. The company is expected to initially target private market opportunities for these LFTs through its own distribution network. The new PathFlow Covid-19 antigen tests are small, instrument-free and enable safe sample collection, testing, reading and disposal by healthcare professionals or patients at their homes. Avacta Group , a diagnostics and innovative cancer therapies developer, announced that a study found its AffiDX® antigen lateral flow test can successfully detect the Delta variant in clinical Covid-19 samples. This test also seemed to beat two other lateral flow antigen tests that are commercially available in Europe. Clinical data for Avacta’s test found it to have 100% sensitivity in detecting infectious individuals with viral loads of Ct<27 via a PCR test, where patients are considered to be contagious. BGI Americas , a diagnostic testing solutions provider, has entered into a partnership with Advaite, a biotech company, and announced the launch of dxpartnerships.com, a hub for diagnostics companies looking for partnerships based on licensing, distribution agreements and original equipment manufacturers. The partnership is expected to add Advaite’s RapCov rapid Covid-19 test to BGI’s portfolio of diagnostic testing solutions and combine Advaite’s handheld test with its real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. Related Companies

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Advaite Patents

Advaite has filed 1 patent.

The 3 most popular patent topics include:

  • Corticosteroid esters
  • Diketones
  • Fluoroarenes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/1/2018

7/13/2021

Glucocorticoids, Pregnanes, Fluoroarenes, Diketones, Corticosteroid esters

Grant

Application Date

3/1/2018

Grant Date

7/13/2021

Title

Related Topics

Glucocorticoids, Pregnanes, Fluoroarenes, Diketones, Corticosteroid esters

Status

Grant

Advaite Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Advaite Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.